BioAge Labs, Inc.

Pharmaceutical company · Emeryville, California, United States · Nasdaq: BIOA

BioAge Labs, Inc. is a pharmaceutical company headquartered in Emeryville, California, United States. Its shares trade on Nasdaq under the ticker BIOA. It has reported private securities offerings to the US SEC, most recently $194 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

BioAge Labs at a glance

Typepharmaceutical company

HeadquartersEmeryville, California, United States

Stock listingNasdaq: BIOA

SEC industryPharmaceutical Preparations

SEC CIK1709941

What does BioAge Labs do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $194.4 million sold (2024).

Frequently asked questions about BioAge Labs

Where is BioAge Labs headquartered?

BioAge Labs, Inc. is headquartered in Emeryville, California, United States.

What does BioAge Labs do?

BioAge Labs, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is BioAge Labs a public company?

Yes. BioAge Labs, Inc. trades on Nasdaq under the ticker BIOA.

Similar companies

Dynavax Technologies CorpEmeryville, California, United States
Zogenix, Inc.Emeryville, California, United States
Bionovo IncEmeryville, California, United States
NovaBay Pharmaceuticals, Inc.Emeryville, California, United States
Adamas Pharmaceuticals IncEmeryville, California, United States
Santen IncorporatedEmeryville, California, United States
TruTag Technologies, Inc.Emeryville, California, United States
AbbVie Inc.North Chicago, Illinois, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences